0001567619-18-002345.txt : 20180910
0001567619-18-002345.hdr.sgml : 20180910
20180910110303
ACCESSION NUMBER: 0001567619-18-002345
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180615
FILED AS OF DATE: 20180910
DATE AS OF CHANGE: 20180910
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Geiger Uri
CENTRAL INDEX KEY: 0001467361
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51481
FILM NUMBER: 181061777
MAIL ADDRESS:
STREET 1: 221 LATHROP WAY, SUITE I
CITY: SACRAMENTO
STATE: CA
ZIP: 95815
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: STRATA Skin Sciences, Inc.
CENTRAL INDEX KEY: 0001051514
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 133986004
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 LAKESIDE DRIVE
STREET 2: SUITE 100
CITY: HORSHAM
STATE: PA
ZIP: 19044
BUSINESS PHONE: 215-619-3200
MAIL ADDRESS:
STREET 1: 100 LAKESIDE DRIVE
STREET 2: SUITE 100
CITY: HORSHAM
STATE: PA
ZIP: 19044
FORMER COMPANY:
FORMER CONFORMED NAME: MELA SCIENCES, INC. /NY
DATE OF NAME CHANGE: 20100504
FORMER COMPANY:
FORMER CONFORMED NAME: ELECTRO OPTICAL SCIENCES INC /NY
DATE OF NAME CHANGE: 19971216
4
1
doc1.xml
FORM 4
X0306
4
2018-06-15
0
0001051514
STRATA Skin Sciences, Inc.
SSKN
0001467361
Geiger Uri
C/O STRATA SKIN SCIENCES, INC.
100 LAKESIDE DRIVE, SUITE 100
HORSHAM
PA
19044
1
0
0
0
SSKN Common Stock
2018-06-15
4
J
0
75590
1.09
A
12122627
I
see footnote
6/15/18 the reporting person was entitled to receive 75,590 shares of the common stock pursuant to a "retained risk" provision in the Securities Purchase Agreement between the Company and Accelmed Growth Partners, L.P. dated 5/29/18 ("Purchase Agreement"). Purchase Agreement provided that the purchaser would receive additional shares of common stock in the event of certain contingent expense events, one of which was determined to have occurred on 6/15/18, resulted in the purchaser acquired additional shares. The number of shares issuable pursuant to that provision, determined on 6/15/18 pursuant to a formula set forth in the Purchase Agreement provided that, for purposes of determining the number of shares issuable, the common stock would be valued at $1.09 per share, which was the purchase price of the common stock in the Purchase Agreement.
Consists of 12,112,627 shares of the common stock held by Accelmed Growth Partners, L.P. Uri Geiger is the controlling member and managing partner of Accelmed Growth Partners (AGP) Limited, which is the general partner of Accelmed Growth Partners (GP), L.P., which is the general partner of Accelmed Growth Partners, L.P. and as a result Uri Geiger may be deemed to beneficially own the shares of common stock held by Accelmed Growth Partners, L.P. Uri Geiger is the controlling shareholder and managing partner of Accelmed Growth Partners Management Ltd., which has certain voting and dispositive power over the 12,112,627 shares of common stock owned by Accelmed Growth Partners, L.P. pursuant to a management agreement, and as a result Uri Geiger may be deemed to beneficially own the shares of the common stock held by Accelmed Growth Partners, L.P.
/s/ Uri Geiger
2018-09-10